Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024530 (
malaria
)
44,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although cerebral
malaria
is a major life-threatening complication of Plasmodium falciparum infection, its pathophysiology is not well understood. Prolonged activation of the T helper type 1 (Th1) response characterized by the production of pro-inflammatory cytokines such as IFN-gamma and TNF-alpha has been suggested to be responsible for immunopathological process leading to cerebral
malaria
unless they are downregulated by the anti-inflamatory cytokines produced by the Th2 response. The T cell immunoglobulin and mucin domain (TIM) family of proteins are cell surface proteins involved in regulating Th1 and Th2 immune responses. In this study, the possible association between the polymorphisms of
TIM1
, TIM3, and TIMD4 genes and the severity of
malaria
was examined in 478 adult Thai patients infected with P. falciparum
malaria
. The
TIM1
promoter haplotype comprising three derived alleles, -1637A (rs7702919), -1549C (rs41297577) and -1454A (rs41297579), which were in complete linkage disequilibrium, was significantly associated with protection against cerebral
malaria
(OR = 0.41; 95% CI = 0.24-0.71; P= 0.0009). Allele-specific transcription quantification analysis revealed that the level of mRNA transcribed from
TIM1
was higher for the protective promoter haplotype than for the other promoter haplotype (P= 0.004). Engagement with
TIM1
in combination with T cell receptor stimulation induces anti-inflammatory Th2 cytokine production, which can protect the development of cerebral
malaria
caused by overproduction of pro-inflammatory Th1 cytokines. The present results suggest that the higher
TIM1
expression associated with the protective
TIM1
promoter haplotype confers protection against cerebral
malaria
.
...
PMID:Significant association between TIM1 promoter polymorphisms and protection against cerebral malaria in Thailand. 1829 62